ArticleThe oncologist2024

Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).

Yosuke Kito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.